Results

Total Results: 1,134 records

Showing results for "days".

101. Cannabis-2022-Surv-Rep-4-Tables-F1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
     January 01, 2022 - NR 2 NR NR NR Excluded Weak opioids: 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days … 1 to 5: 3 mg 3 times/d; days 6 to 10: 5 mg 3 times/day; days 11 to 52: 8 mg 3/day Range: 15 to 24 mg … 2012 RCT No No Europe NPP Multiple sclerosis Excluded patients with previous use of cannabis in the 30 days … Chronic pancreatitis and postsurgical abdominal pain THC oral tablet (Dronabinol): titrated over 10 days … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Daily analgesic intake; pain free days

102. Cannabis-2023-Surv-Rep-4-Tables-E-1-E-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
     January 01, 2023 - NR 2 NR NR NR Excluded Weak opioids: 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days … 1 to 5: 3 mg 3 times/d; days 6 to 10: 5 mg 3 times/day; days 11 to 52: 8 mg 3/day Range: 15 to 24 mg … 2012 RCT No No Europe NPP Multiple sclerosis Excluded patients with previous use of cannabis in the 30 days … Chronic pancreatitis and postsurgical abdominal pain THC oral tablet (Dronabinol): titrated over 10 days … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Daily analgesic intake; pain free days

103. Research Review Title: Infection Prevention and Control for the Emergency Medical Services and 911 Workforce (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-disposition-comments.pdf
     November 01, 2022 - The median interval between days where a provider cared for a COVID-19 patient and EMS provider positive … COVID-19 PCR swab was 73 days –well outside the incubation period of SARS-CoV-2. … Murphy et al, 2020) in preventing COVID-19 infections, in that there was a total of 288,032 person days … infections (one of 30) were attributable to patient care despite hundreds of thousands of person days … had a COVID-19 patient encounter but did not develop infection within the exposure window of 2-14 days

104. Observed Association Between Antidepressant Use and Pneumonia Risk Was Confounded by Comorbidity Measures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
     May 01, 2008 - The index date for controls was defined as the date of entry into the study base plus the number of days … tendency (i.e., mode and median) for repeat prescriptions to be issued approximately every thirty days … ever in the past (as markers of disease), currently prescribed drugs (i.e., within the past thirty days … and health care utilization (e.g., number of non-antidepressant prescriptions in the prior thirty days … , number of GP visits for non-depression diagnoses in the prior thirty days, number of hospitalizations

105. Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
     June 01, 2017 - appeared substantial in quantity and persisted despite treatment with anti- microbial drugs for 90 days … of randomization or a systemic corticosteroid within 7 days of randomization; any infection requiring … Number of acute otitis media episodes 11 Study Outcomes Quality of life Secondary: Number of days … , 95% CI 3.74 to 5.52), when compared to ciprofloxacin alone (median 6.83 days, 95% CI 5.49 to 7.74) … or fluocinolone acetonide alone (median 22 days, 95% CI 13.93 to 22).

106. Procalcitonin Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/procalcitonin_executive.pdf
     October 01, 2012 - bCalculated by multiplying the total number of antibiotics by the number of days the patient is receiving … on mechanical ventilation, and increased days with abnormal renal function. … Evidence was insufficient to judge effects on days of restricted activity or on antibiotic adverse … per 1,000 days of followup. … to all antibiotics per 1,000 days of followup. 2.

107. Cannabis-2022-Surv-Rep-3-Tables-F1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
     January 01, 2022 - NR 2 NR NR NR Excluded Weak opioids: 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days … 1 to 5: 3 mg 3 times/d; days 6 to 10: 5 mg 3 times/day; days 11 to 52: 8 mg 3/day Range: 15 to 24 mg … 2012 RCT No No Europe NPP Multiple sclerosis Excluded patients with previous use of cannabis in the 30 days … Chronic pancreatitis and postsurgical abdominal pain THC oral tablet (Dronabinol): titrated over 10 days … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Daily analgesic intake; pain free days

108. Amended Protocol: Maternal and Childhood Outcomes Associated with the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/wic-outcomes-nutrition-protocol-amended.pdf
     October 01, 2020 - 2 Population Women who participated in WIC during pregnancy and their infants at birth up to 28 days … maternal nutritional status at enrollment Infants/children who participated in WIC (age from 29 days … eligible for WIC, but did not participate during pregnancy, and their infants at birth up to 28 days … Population KQ1: Women who participated in WIC during pregnancy and their infants up to age 28 days … KQ2: Infants/Children who participated in WIC (ages 29 days up to age 5) • Animal studies

109. Dietary-Supplements Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - pharmacokinetic study of American and Korean ginseng and either 3 doses of 5 mg warfarin over 3 days … clinically significant interactions Healthy volunteer studies based on therapeutic doses of statins for 14 days … Hawthorn In a trial of hawthorne (84.3 mg/day of oligomeric procyanidines) added to digoxin for 21 days … versus digoxin alone for 10 days, no significant differences in pharmacokinetic outcomes were observed

110. Coronary-Artery-Stenting Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
     February 01, 2013 - Outcomes were measured at three time points: short term (≤30 days after the procedure), medium term … (>30 days to 1 year), and long term (>1 year). 4 We excluded studies that solely compared stenting … None of the nonrandomized comparative studies reported data on hospital days or data on medication use … Patient-Centered Outcomes Short-term (≤ 30 days after the procedure), patient- centered outcomes in … For the medium term (>30 days to 1 year), both RCTs and nonrandomized studies reported no significant

111. Cer-250-Cannabis-2025-Surv-Rep-Update-Tables-E1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
     January 01, 2025 - NR 2 NR NR NR Excluded Weak opioids: 21/50 Strong opioids: 26/50 65 50 THC oral tablet (Dronabinol): days … 1 to 5: 3 mg 3 times/d; days 6 to 10: 5 mg 3 times/day; days 11 to 52: 8 mg 3/day Range: 15 to 24 mg … 2012 RCT No No Europe NPP Multiple sclerosis Excluded patients with previous use of cannabis in the 30 days … Chronic pancreatitis and postsurgical abdominal pain THC oral tablet (Dronabinol): titrated over 10 days … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Daily analgesic intake; pain free days

112. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
     May 13, 2014 - When including all studies, subjects treated with naltrexone had 3.8 percent fewer heavy drinking days … TEP Reviewer #2 General For sertraline, under Drinking Days. … Some such as "number of heavy drinking days" require a more explicit definition. … Heavy drinking days were defined as ≥4 drinks/day for women and ≥5 drinks/day for men. … I suspect for outcomes such as percentage of drinking days and percentage of heavy drinking days, the

113. Alcohol-misuse-drug-therapy-140326 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
     January 27, 2012 - under the concept of harm reduction.32 These measures include significant increases in abstinent days … sobriety over 1 year, the remaining nonabstinent individuals showed substantial decreases in drinking days … Consumption outcomes  abstinence/any drinking - rates of continuous abstinence - percentage of days … - time to heavy drinking/relapse  reduction in alcohol consumption - number of heavy drinking days … - percent of subjects with no heavy drinking days - number of drinking days - drinks per drinking

114. Crosscutting-Horizon-Scan-High-Impact-1312 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - or inpatient hospital setting are referred to a postdischarge clinic for an appointment within 2 days … shorter in [postdischarge clinic] (PDC) than primary care followup (PDC, 3.8 days; urgent care, 5.0 … days; primary care, 6.2 days; p=0.04 between groups). … Study authors reported, “The median duration from hospitalization to first visit was 7 days in the … PDC and 15 days elsewhere in HCA (adjusted difference = 8.45 +/- 0.43 days; P < 0.001).

115. Evidence-based Practice Center Systematic Review Protocol: Prehospital Airway Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prehospital-airway-management-protocol.pdf
     December 20, 2019 - survival o To arrival at hospital o To hospital discharge o Any period less than or equal to 30 days … Performance Category o Pneumothorax o Aspiration pneumonia • Length of Stay o Hospital length of stay (days … ) o ICU length of stay (days) o ICU-free days Intermediate Outcomes (secondary priority) • Overall … Barotrauma • Misplaced tube • Need for additional airway interventions Long-term outcomes (more than 30 days

116. Disposition of Comments for Comparative Effectiveness Review 133 Transitional Care Interventions To Prevent Readmissions for People With Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
     May 27, 2014 - There is no reason to think that readmissions within 30 days do not represent natural history of HF … Not all readmissions within 30 days are preventable. … In fact, you only had 1 study (I think) that looked at 30 days. … , We were interested in trials recruiting patients during or within the 7 days following discharge. … vs. 31 days?

117. S149 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
     October 01, 2007 - claims for prescription drugs, including the drug name, pre- scription fill date, and the number of days … September–October 2005); and (2) if the patient had sufficient drug-on-hand for more than 50% of the days … 68%) could be considered to be “on-time,” with the median time to filling a next prescription of 33 days … (mean was 35 days). … fill date), the median fill time was 47 days after the previous fill (mean was 52 days after).

118. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - (1–5 days). … No complications occurred requiring intensive care, hospital stays longer than 5 days, surgical or … per week by 1 or more days, compared with 23% of patients treated with placebo experiencing such … Additionally, after 12 months of teduglutide treatment, 53% of patients reduced their infusion days … per week, and 24% of patients reduced their infusion days per week by 3 or more days.

119. EHC Research Protocol (Amended): Treatments for Acute Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
     January 09, 2020 - MOH is operationally defined based on headache frequency (15 or more days per month for greater than … 3 months) and days of use per month of specific medications.8 Triptans, ergots alkaloids, combination … analgesics, or opioids on 10 or more days per month meets criteria for medication overuse. … analgesics including 2 nonsteroidal anti-inflammatory drugs (NSAIDs) used on 15 or more days … addition, use of more than one class of medications, for example a triptan and an NSAID, on 10 or more days

120. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
     January 01, 2021 - 2021 US NR Telehealth Inclusion: Participants aged 21 to 70 years with back pain for at least half the days … Hatha yoga (n=75): Two 60 minute sessions per week for 12 weeks, 15–20 minutes of home practice on days … C 6 months Opioid Days: 1.61 (0.91) vs. 2.93 (0.93), p=0.31 B vs. … C 3 days RMDQ: 11.2 vs. 11.0, p=NR NPS: 4.3 vs. 2.7, p=NR 3 day change from baseline RMDQ: NR vs. … C 3 days RMDQ: 12.2 vs. 11.0, p=NR NPS: 3.4 vs. 2.7, p= NR 3 day change from baseline RMDQ: NR vs.